Connect with us

Subscribe

Cancer

inotuzumab ozogamicin

A drug used to treat B-cell acute lymphoblastic leukemia (ALL) that has not gotten better with other treatment or has recurred (come back). It is also being studied in the treatment of other types of cancer. Inotuzumab ozogamicin contains a monoclonal antibody that binds to a protein called CD22, which is found on some leukemia cells. It also contains a toxic substance, which may help kill cancer cells. Inotuzumab ozogamicin is a type of antibody-drug conjugate. Also called Besponsa.

( ih-noh-TOO-zoo-mab OH-zoh-ga-MIH-sin )
Source: NCI Dictionary of Cancer Terms

Search the Glossary of Medical Terms

Inqovi
Newsletter

Sign up for the QuackTrack.org newsletter below!

Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

QuackTrack on Twitter

Trending Posts

Connect
Newsletter

Sign up for the QuackTrack.org newsletter below!